According to these findings, it was proposed that SF3B1 mutations help to define a subgroup of uveal melanomas associated with metastatic risk that is intermediate between uveal melanomas with BAP1 mutations (high risk) and uveal melanomas with EIF1AX mutations (low risk). The gene discussed is BAP1; the disease is uveal melanoma.